Company Profile

Organ Recovery Systems Inc (AKA: Life Resuscitation Technologies Inc)
Profile last edited on: 1/24/19      CAGE:       UEI:

Business Identifier: Recovery, transport, preservation, and assessment of donated organs for transplantation
Year Founded
1998
First Award
1998
Latest Award
2005
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

One Pierce Place Suite 475W
Itasca, IL 60143
   (847) 824-2600
   info@organ-recovery.com
   www.organ-recovery.com
Location: Multiple
Congr. District: 08
County: DuPage

Public Profile

Organ Recovery Systems, Inc ir organized around development of technology and services to improve quality and quantity of organs and cells for transplantation. Formerly VC funded, the firm now operates as a wholly owned subsidiary of Shanghai Genext Medical Technology Company Ltd founded in 2003 and based in Shanghai, China. . Employing techniques of low temperature technologies for the recovery, transport, preservation and storage of complex living biological materials (e.g. organs, tissues) for bio-medical applications, the company is organized into three operating groups: the Perfusion Services Group helps transplant centers and organ procurement organizations (OPOs) by employing proprietary perfusion techniques for evaluation and therapy of traditional, expanded criteria, and nonheartbeating donor kidneys prior to transplant; the Medical Devices Group develops perfusion-based devices to improve the preservation, assessment, and treatment of organs for transplantation; and the Charleston Research Center develops new technologies for cell and tissue preservation and conducts basicmore

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
25-49

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2005 2 NIH $901,359
Project Title: Vitrification For Tissue Engineered Blood Vessels
2004 1 NIH $157,928
Project Title: pH Management in Hypothermically Stored Cardiomyocytes
2004 1 NIH $119,076
Project Title: Ice-Free Preservation of Ovaries for Long-Term Fecundity
2004 2 NIH $652,302
Project Title: Development Of Cryoplates For Cytotoxicity Testing
2003 1 NIH $122,006
Project Title: Preservation of Myocardial Tissue-Engineered Constructs

Key People / Management

  David Kravitz -- President

  Simona C Baicu

  John Brassil

  Kelvin G Brockbank

  Ying C Song

  John R Walsh

Company News

There are no news available.